Form 4: Fuller H. B. Co. Insider Trading Activity
Statement of Changes in Beneficial Ownership
Celeste Beeks Mastin, Director and President & CEO of Fuller H. B. Co., reported a transaction involving the acquisition of 5,170 shares of common stock.
Summary
- Celeste Beeks Mastin, who holds the positions of Director and President & CEO at Fuller H. B. Co., has reported a transaction on April 7, 2026.
- The transaction involved the acquisition of 5,170 shares of common stock at a price of $57.08 per share.
- Following this transaction, Mastin beneficially owns 8,670 shares directly through a Revocable Trust and an additional 32,873 shares directly.
- The filing also details various stock options and restricted stock units held by Mastin, with vesting schedules and exercise prices specified.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing due to the insider purchase, which can signal confidence, but it does not provide new financial performance data.
Positives
- Insider purchase of 5,170 shares by a key executive (President & CEO) and director, indicating confidence in the company.
- The acquisition was made at a price of $57.08 per share, which may represent a favorable entry point for the executive.
Future Outlook
The filing does not contain forward-looking statements or guidance. It is a report of insider transactions.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The purchase of common stock by a high-ranking executive like the President & CEO can be interpreted as a positive signal of their belief in the company's future prospects.
Stakeholder Impact
- Shareholders may view the insider purchase positively, interpreting it as a sign of executive confidence in the company's value and future performance.
- Employees may be encouraged by the commitment shown by senior leadership through their investment in the company's stock.
Key Dates
| Date | Description |
|---|---|
| 04/07/2023 | Vesting date for employee stock option with exercise price $67.55. |
| 01/24/2024 | Vesting date for employee stock option with exercise price $68.17. |
| 01/26/2025 | Vesting date for employee stock option with exercise price $77.72. |
| 01/26/2025 | Vesting date for restricted stock units with a conversion price of $0.0000. |
| 01/27/2026 | Vesting date for employee stock option with exercise price $64.28. |
| 01/27/2026 | Vesting date for restricted stock units with a conversion price of $0.0000. |
| 01/26/2027 | Vesting date for restricted stock units with a conversion price of $0.0000. |
| 01/26/2036 | Expiration date for employee stock option with exercise price $59.81. |
| 01/27/2035 | Expiration date for employee stock option with exercise price $64.28. |
| 04/07/2032 | Expiration date for employee stock option with exercise price $67.55. |
| 01/24/2033 | Expiration date for employee stock option with exercise price $68.17. |
| 01/26/2034 | Expiration date for employee stock option with exercise price $77.72. |
| 01/26/2027 | Expiration date for restricted stock units with a conversion price of $0.0000. |
| 01/27/2028 | Expiration date for restricted stock units with a conversion price of $0.0000. |
| 04/07/2026 | Transaction date for acquisition of common stock and earliest transaction date. |
Keywords
Form 4, Insider Trading, Beneficial Ownership, Common Stock, Stock Options, Restricted Stock Units, Fuller H. B. Co., Celeste Beeks Mastin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.